Suchergebnisse - "Fan, Zhiping"

PubPharm (7)

1

Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation : A Multicenter Randomized Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Ling, Y. | Xuan, L. | Xu, N. | +20

2

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia : long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Xuan, L. | Wang, Y. | Yang, K. | +21

CommentIn: Lancet Haematol. 2023 Aug;10(8):e559-e561. - PMID 37532412

3

Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate-risk acute myeloid leukemia in first complete remission undergoing auto-HSCT : An open-label, multicenter, randomized phase 3 trial

enthalten in: American journal of hematology | 2023

von Liu, H. | Huang, F. | Zhang, Y. | +16

4

The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation : an open-label, multicentre, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Xuan, L. | Dai, M. | Jiang, E. | +17

CommentIn: Lancet Haematol. 2023 Mar;10(3):e159-e160. - PMID 36702139

5

Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia : An Open-Label, Multicenter, Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Zhang, H. | Fan, Z. | Huang, F. | +22

CommentIn: J Clin Oncol. 2023 Mar 1;41(7):1496-1497. - PMID 36595732

6

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease : a multicenter, randomized, phase 3, open-label trial

enthalten in: Journal of hematology & oncology | 2022

von Zhao, K. | Lin, R. | Fan, Z. | +17

7

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation : an open-label, multicentre, randomised phase 3 trial

enthalten in: The Lancet. Oncology | 2020

von Xuan, L. | Wang, Y. | Huang, F. | +19

CommentIn: Lancet Oncol. 2020 Sep;21(9):1130-1132. - PMID 32791049

1
[1]